Lawmakers eye more oversight of dietary supplements and cosmetics

Lawmakers eye more oversight of dietary supplements and cosmetics

Top lawmakers on the Senate health committee are proposing to beef up FDA oversight of dietary supplements, cosmetics and lab-developed tests as part of a sweeping plan to reauthorize regulatory programs.

Why it matters: The agency has faced challenges looking out for unproven claims or companies that aren’t safely manufacturing products.

Where it stands: A draft plan released Tuesday by Senate HELP Committee Chair Patty Murray (D-Wash.) and Ranking Member Richard Burr (R-N.C.) would, among other things, require premarket approval of supplements and make manufacturers disclose what’s in their products.

  • The FDA lacks authority to approve supplements, and firms generally don’t have to provide evidence for the FDA to conclude the products are safe.
  • Some supplement manufacturers are aggressively fighting the plan: The Natural Products Association says it would drive up consumer costs and weaken privacy protections for the industry’s supply chain.

Go deeper: Murray and Burr’s plan would also address the agency’s oversight of lab-developed tests, which became a friction point during the Trump administration.

  • And it would require cosmetics manufacturers to track and report adverse events involving their products and make the FDA set good manufacturing practices.
  • The proposals are wrapped in a larger package that would renew FDA user fees that help fund the agency’s product evaluations.
  • Any plan that emerges from the Senate would still have to be blended with a House FDA reform package.